Delivery Order SPE2DR25D2101-SPE2DR26F46LR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Emgality 120 mg/ml pen injectors, valued at $2,840.86 under firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 15, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary headquarters and...
- The Defense Logistics Agency (DLA) awarded a $1,506.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/mL pen injectors on December 11, 2025, with an ultimate completion date of December 12, 2025. This is a non-set-aside competitive award issued as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Emgality 120 mg/mL pen injectors, valued at $1,556.10. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a non-competitive set-aside award. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Emgality 120 mg/ml pen injectors, with a ceiling value of $1,527.12. This is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,859.02 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on November 7, 2025, with completion targeted for November 10, 2025. This non-competitive, competitively awarded delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency awarded a $1,378.65 firm fixed price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors, with an ultimate completion date of August 14, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfillment through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product is a migraine treatment medication that will be delivered to the contracting location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors valued at $3,013.20, with a firm fixed price and ultimate completion date of December 12, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $1,674.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on December 8, 2025, with an ultimate completion date of December 9, 2025. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction under AmerisourceBergen's existing federal contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $1,729.00 delivery order to AmerisourceBergen Drug Corp for Emgality 120 mg/ml pen injectors on August 5, 2025, with an ultimate completion date of August 6, 2025. This contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement fulfilling...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Emgality 120 mg/ml pen injectors, valued at $3,458.00. This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by August 7, 2025, with performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- SPE2DR25D2101Indefinite Delivery Contract
- SPE2DR25D2101-SPE2DR26F46LRDelivery Order
The Defense Logistics Agency awarded a $1,665.04 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Emgality 120 mg/mL pen injectors. This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 15, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction for this specialized pharmaceutical product used in migraine treatment, reflecting the company's role as a critical supplier within the federal medical supply chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, consistently fulfills federal procurement requirements through open competition and maintains a robust portfolio of medications spanning multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 12/11/25 |